12:00 AM
 | 
Jan 31, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

North American Vaccine preclinical data

NVX reported that in mice the combination of its Hib and acellular pertussis vaccines produced no significant immunologic interferences. NVX plans to market the...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >